The HEARTEN project will develop biosensors that detect and quantify novel breath and saliva HF biomarkers that reflect the health status of the patient and identify whether the patient adheres to the administered drugs.
Breath biosensor integrated into smartphone
The breath biosensor will be integrated into the smartphone while the saliva biosensor will be integrated into the patient’s cup.
Additional sensors for monitoring the ECG, the blood pressure and the physical activity constitute the sensor kit of the patient. The input data are complemented with nutritional information from the patient’s smartphone, weight monitoring through wireless weight scales as well as the patient’s profile and information directly added by the caregivers and the healthcare professionals.
These multi-parametric data are then transmitted to the HEARTEN cloud reference architecture, where a knowledge management system analyses them and delivers critical information at hand, provides alerts, guidelines, trends and predictive models to the patient and the ecosystem actors.
Empowered in self-management
HF patients will be empowered in self-management, by using their smartphones and tracking their medical vital signs, while the healthcare professionals and the caregivers can issue warnings, coordinate therapies, improve adherence and intervene before frailty incidences occur.
"In HEARTEN, the patient has a central role in the corresponding ecosystem and is empowered through an easy-to-use sensor kit and apps to manage his or her status," says project coordinator Prof. Abdelhamid Errachid (University of Lyon).
'We want to not only avoid HF situations, but also support and educate the patient'
Errachid: "As our newly developed personalized system empowers direct and immediate indication of disease conditions such as metabolic or oxidative stress, it will not only help to avoid critical situations but also support and educate the patient to reduce conditions leading to such situations and therefore support health education and self-management in general."
Background
The three-year project targets heart failure (HF), a disease experienced globally by 26 million people with an annual cost to insurers estimated to be approximately 6.000€ per person. The recognition of non-adherent HF patients is important since, even if these patients are fortunate to have at their disposal a plethora of guidelines and health-based knowledge, the integration of this knowledge in their life becomes difficult. Developing and delivering an ICT co-operative environment that will enable the HF patients to achieve sustainable behavior change regarding their adherence and compliance is a significant challenge.
HEARTEN is a project funded through the Horizon 2020 programme of the European Union, with twelve partners from six European countries; three Universities, two research centres, five SMEs, one industry partner and one Healthcare authority partner.
HEARTEN consortium has joined forces to engage all actors related to the management of patients suffering from HF, towards developing a multi-stakeholder patient-centred mHealth ecosystem.
Partners
- UNIVERSITE LYON 1 CLAUDE BERNARD (France),
- LYON INGENIERIE PROJETS (France),
- EVERIS SPAIN SL (Spain),
- APPART SA (Greece),
- FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS (Greece),
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (Spain),
- UNIVERSITATSMEDIZIN ROSTOCK (Germany),
- UNIVERSITA' DI PISA (Italy),
- SERVICIO ANDALUZ DE SALUD (Spain),
- YOUR DATA SRL (Italy),
- CAREDOME PATIENT SUPPORT AND HEALTHCARE SOLUTIONS (Portugal),
- SESA NV Srl (Italy).
Website: www.hearten.eu